XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.23.1

RESTRUCTURING | 3 Months Ended
--- | ---
Mar. 31, 2023
Restructuring Charges [Abstract] |
Restructuring | RESTRUCTURING Celgene Acquisition Plan As part of the Celgene Acquisition Plan, the Company expects to incur charges of approximately $3.5 billion, including cash outlays of approximately $3.1 billion. Cumulative charges of approximately $3.1 billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. Other Restructuring Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition in 2022 and the MyoKardia acquisition in 2020. Charges of approximately $250 million are expected to be incurred through the end of 2023 and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $180 million have been recognized for these actions to date. In the first quarter of 2023, certain restructuring activities occurred resulting in employee termination costs of $61 million, which are primarily attributed to changes in our operating model to accelerate the delivery of medicines to patients. The following provides the charges related to restructuring initiatives by type of cost:
| Three Months Ended March 31, |  |
Dollars in millions | 2023 |  | 2022 |  |  |  |
Celgene Acquisition Plan | $ | 57 |  |  | $ | 127 |  |  |  |  |
Other Restructuring | 78 |  |  | 3 |  |  |  |  |
Total charges | $ | 135 |  |  | $ | 130 |  |  |  |  |
Employee termination costs | $ | 65 |  |  | $ | 22 |  |  |  |  |
Other termination costs | 2 |  |  | 1 |  |  |  |  |
Provision for restructuring | 67 |  |  | 23 |  |  |  |  |
Integration expenses | 67 |  |  | 105 |  |  |  |  |
Accelerated depreciation | 1 |  |  | 2 |  |  |  |  |
Total charges | $ | 135 |  |  | $ | 130 |  |  |  |  |
Cost of products sold | $ | 1 |  |  | $ | — |  |  |  |  |
Marketing, selling and administrative | — |  |  | 2 |  |  |  |  |
Other (income)/expense, net | 134 |  |  | 128 |  |  |  |  |
Total charges | $ | 135 |  |  | $ | 130 |  |  |  |  |
The following summarizes the charges and spending related to restructuring plan activities:
| Three Months Ended March 31,
Dollars in millions | 2023 |  | 2022
Beginning balance | $ | 47 |  |  | $ | 101 |
Provision for restructuring(a) | 67 |  |  | 23 |
Foreign currency translation and other | 2 |  |  | (1) |
Payments | (17) |  |  | (21) |
Ending balance | $ | 99 |  |  | $ | 102 |
(a) Includes a reduction of the liability resulting from changes in estimates of $3 million and $9 million for the three months ended March 31, 2023 and 2022, respectively.

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(e)) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI https://asc.fasb.org/topic&trid=2175745 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration